Veracyte, Inc. announced the appointment of Dr. Kevin Haas as Chief Development and Technology Officer, effective March 24, 2026, with a salary of $500,000 and stock awards totaling $3 million over four years. This appointment was reported on March 16, 2026, following a previous announcement on March 13, 2026.